CDK2 and lung cancer: In NSCLC, CCNE1 (Cyclin E1) focal amplification indicates hyperactivation of the Cyclin E–CDK2 axis and aligns with evidence that Cyclin E overexpression is a negative prognostic factor in lung cancer [28].